These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 14380678)

  • 1. [The effect of ganglion blocking agents on bladder hypertension and its clinical significance; experimental studies with hyoscine-n-butylbromide (buscopan)].
    EUFINGER H
    Geburtshilfe Frauenheilkd; 1955 Feb; 15(2):166-71. PubMed ID: 14380678
    [No Abstract]   [Full Text] [Related]  

  • 2. [The effects of hyoscine-N-butylbromide (buscopan) on the motility of the gallbladder].
    SCHNAYDER K; SPANGLER H
    Klin Med Osterr Z Wiss Prakt Med; 1954 Feb; 9(2):74-9. PubMed ID: 13164209
    [No Abstract]   [Full Text] [Related]  

  • 3. [Studies on the pharmacologic effect and clinical use of hyoscine-N-butylbromide (buscopan)].
    HEINKEL K
    Dtsch Z Verdau Stoffwechselkr; 1951 Jul; 11(4):180-95. PubMed ID: 14872696
    [No Abstract]   [Full Text] [Related]  

  • 4. [Inhibiting effect of hyoscine N-butylbromide on experimental auriculo-ventricular block produced by tetraethylammonium bromide].
    PELUFFO G; MEZZANO M
    Arch Maragliano Patol Clin; 1953; 8(5):1061-6. PubMed ID: 13125772
    [No Abstract]   [Full Text] [Related]  

  • 5. Hyoscine butylbromide: a useful premedicant.
    Fry EN
    Anaesthesia; 1975 Jul; 30(4):549-50. PubMed ID: 1096666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The effect of hyoscine-n-butylbromide on postanesthetic nausea and ether narcosis].
    BUSCH K
    Hippokrates; 1953 Nov; 24(22):696-8. PubMed ID: 13142548
    [No Abstract]   [Full Text] [Related]  

  • 7. [Hyoscine N-butylbromide in radiation sickness].
    CORNELIO G; ORLANDI C
    Arcisp S Anna Ferrara; 1954; 7(1):79-85. PubMed ID: 13198665
    [No Abstract]   [Full Text] [Related]  

  • 8. [Research on the pharmacological interference between tetraethylammonium bromide and hyoscine N-butylbromide on guinea pig heart].
    PELUFFO G; MEZZANO M
    Boll Soc Ital Biol Sper; 1953 Jul; 29(7):1485-6. PubMed ID: 13140583
    [No Abstract]   [Full Text] [Related]  

  • 9. [Spasmolytic effects of the vagotropic ganglion blocking agent buscopan on tube spasms].
    KRONIG OJ
    Zentralbl Gynakol; 1954; 76(28):1098-1103. PubMed ID: 13196619
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical contribution to the study of hyoscine N-butylbromide (B 2011)].
    FORET J; SIMILON A
    J Belge Urol; 1952 Dec; 21(2):55-8. PubMed ID: 13044763
    [No Abstract]   [Full Text] [Related]  

  • 11. [Brief notes on the effect of Nbutylbromide of hyoscine (buscopan) in spastic visceral syndromes secondary to telecobaltotherapy].
    CAUMO A
    Gazz Med Ital; 1958 Apr; 117(4):150-2. PubMed ID: 13548388
    [No Abstract]   [Full Text] [Related]  

  • 12. [Atropine-like action of butylbromide of hyoscine on isolated cat esophagus].
    GALIOTO GB
    Boll Soc Ital Biol Sper; 1957 Jul; 33(7):1113-4. PubMed ID: 13510450
    [No Abstract]   [Full Text] [Related]  

  • 13. [Further study of the action of hyoscine butylbromide on the motility of isolated cat esophagus].
    GALIOTO GB
    Minerva Otorinolaringol; 1957; 7(6):384-7. PubMed ID: 13516894
    [No Abstract]   [Full Text] [Related]  

  • 14. [Results of the clinical use of a synthetic spasmolytic (scopolamine N-butylbromide) in urology (534 cases)].
    PANSADORO V; CAPRA D
    Policlinico Prat; 1958 Aug; 65(33):1286-92. PubMed ID: 13578730
    [No Abstract]   [Full Text] [Related]  

  • 15. [Temporary plastification of uterine cervix by N-butylbromide hyoscine especially during intravenous anesthesia with thiobarbiturate].
    SABATIER H
    Sem Med Prof Med Soc; 1957 Jan; 33(3):116-9. PubMed ID: 13409034
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical study of scopolamine N-butylbromide].
    PAYFA M
    Scalpel (Brux); 1954 Mar; 107(10):243-9. PubMed ID: 13168231
    [No Abstract]   [Full Text] [Related]  

  • 17. Canadian Association of Gastroenterology (CAG) Position Statement on the Use of Hyoscine-
    Forbes N; Frehlich L; Borgaonkar M; Leontiadis GI; Tse F
    J Can Assoc Gastroenterol; 2021 Dec; 4(6):259-268. PubMed ID: 34877465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The absorption and elimination of orally administered (14C)hyoscine N-butylbromide (butylscopolamine).
    Vapaatalo H; Penttilä A; Kaltiala E
    J Pharm Pharmacol; 1975 Jul; 27(7):542-3. PubMed ID: 239166
    [No Abstract]   [Full Text] [Related]  

  • 19. [The therapeutic effect of a hyoscine-n-butyl compound in abdominal diseases].
    THONE H; EGGERS K
    Med Monatsschr; 1953 Sep; 7(9):580-2. PubMed ID: 13119334
    [No Abstract]   [Full Text] [Related]  

  • 20. [Experimental study of the action of hyocine N-butylbromide on the esophagus of cat].
    GALIOTO GB
    Clin Otorinolaringoiatr; 1954 Oct; 6(5):491-503. PubMed ID: 14364803
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.